NaviGate Cardiac Structures, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From NaviGate Cardiac Structures, Inc.
NaviGate Cardiac Structures Inc.
For patients with severe or irreversible moderate mitral regurgitation, NaviGate Cardiac Structures Inc. is developing a catheter-guided compressible valved stent that fits within the diseased mitral valve in a beating heart.
Start-Up Previews, January 2016
In this month's issue of Start-Up, we profile Alcresta Pharmaceuticals, Gordian Surgical, International Biomedical Devices, NaviGate Cardiac Structures, ObsEva and SweetBio.
Case Study: Cross-Strait Agreement Could Shorten IND Timeframe For Products Entering China (Part 2 of 2)
Global pharmaceutical firms can look no further than across the Taiwan Strait when working to get products approved and launched in China faster.
Australian biotechs fight over Progen
The Melbourne biotech firm Cytopia is challenging a merger between the Australian biotechs Progen Pharmaceuticals and Avexa, saying it can offer a better deal to Progen shareholders.
- Medical Devices
- Other Names / Subsidiaries
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.